Plantar Wart Clinical Trial
Official title:
Intralesional Vitamin D3 Versus Intralesional Acyclovir in Treatment of Plantar Warts
To evaluate and compare the efficacy and safety of intralesional acyclovir versus intralesional vitamin D3 in the treatment of plantar warts
Introduction Warts are common epidermal growths caused by various strains of human papillomavirus (HPV) affecting all age groups. They have an unsightly appearance and are mostly asymptomatic but sometimes may be painful as in the case of palmoplantar warts . Plantar warts is a clinical variant that occur on sole of the foot, most frequently over pressure points . It is estimated that 40% of population is infected with HPV, and in 7% to 12%, a wart develops . Plantar warts exhibit an annual incidence of 14% in the general population . Sixty-five percent to 78% of cutaneous warts have been shown to regress within 2 years . In persons older than 12 years, the rate of spontaneous regression significantly decreases . Variable therapeutic options are available for treating warts, with none considered a gold standard. Primary treatments include topical salicylic acid, topical imiquimod, topical 5-fluorouracil, cryotherapy, excision, electrocautry and laser vaporization . Vitamin D is a fat-soluble steroid prohormone that has wide range of biological actions e.g. inhibition of cellular proliferation, induction of terminal differentiation, and inhibition of angiogenesis. It also stimulates macrophages and cathelicidin production . Recently, several studies have demonstrated the efficacy of intralesional vitamin D in treatment of warts, as well as recalcitrant lesions, with clearance rates of 72.5%-90% . Acyclovir is a synthetic purine nucleoside analogue with activity against some viruses as herpes simplex and varicella-zoster virus. Acyclovir uses viral thymidine kinase to convert to its active form, acyclovir triphosphate. Through this mechanism of utilizing viral thymidine kinase, acyclovir specifically targets viral DNA preventing its replication in the host. Previously, few studies and case reports documented the clearance of warts, some were unresponsive to prior treatment, with both topical and oral use of acyclovir . A recent study has evaluated the efficacy of intralesional acyclovir versus intralesional saline in treatment of warts and reported complete clearance rate of 52.6% and a partial response of 16.7% for acyclovir with a statistically significant difference from saline (0% complete clearance) . ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00328991 -
Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts
|
N/A | |
Completed |
NCT05592041 -
Studying of Natural Constituents' Treatment of Plantar Warts
|
Early Phase 1 | |
Completed |
NCT05115669 -
Safety & Effectiveness of Wortie Freeze Plus in Common and Plantar Warts
|
N/A | |
Recruiting |
NCT06261684 -
Intralesional Acyclovir Versus Cryotherapy in the Treatment of Plantar Warts. A Randomized Controlled Trial.
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT05057663 -
Intralesional Treatment of Plantar Wart
|
N/A | |
Recruiting |
NCT02151630 -
Pyruvic Acid Versus Salicylic Acid Preparation in Treatment of Plantar Warts
|
Phase 2/Phase 3 | |
Withdrawn |
NCT04823845 -
Plantar Wart Treatment Using Adapalene Gel
|
Early Phase 1 | |
Completed |
NCT05588999 -
Comparative Study Between Treatment With Cryotherapy Alone Versus Cryotherapy Plus Salicylic Acid Dressing for Planter Warts
|
Phase 1 | |
Completed |
NCT01536834 -
Safety & Performance Study of Verruca Treatment Device
|
N/A | |
Recruiting |
NCT05488860 -
Piezoelectric Drived Microneedling in Treating Refractory Skin Diseases
|
N/A | |
Recruiting |
NCT05520658 -
Evaluation of the Efficacy of Intralesional Injection of Combined Digoxin and Furosemide Versus 5 - Fluorouracil in Treatment of Plantar Warts
|
N/A | |
Not yet recruiting |
NCT04654091 -
Cryotherapy VS. Nitric-zinc Complex in the Treatment of Plantar Warts.
|
N/A | |
Not yet recruiting |
NCT05599971 -
Intralesional Injection of Combined Digoxin and Furosemide Versus 5-Flurouracil in Plantar Warts
|
N/A | |
Not yet recruiting |
NCT05198180 -
Treatment of Plantar Warts
|
Phase 3 | |
Recruiting |
NCT06214559 -
Evaluate the Effectiveness and the Safety of a Medical Device in the Treatment of Common Warts and Plantar Warts.
|
N/A | |
Recruiting |
NCT03977753 -
Randomized, Placebo-controlled, Double Blind Study to Evaluate the Efficacy of 2LVERU®JUNIOR and 2LVERU® on the Treatment of Warts
|
Phase 4 | |
Completed |
NCT03183765 -
Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts
|
Phase 4 |